ARTICLE | Financial News
Crossovers back Xeris in $41M series C
January 8, 2016 2:21 AM UTC
Xeris Pharmaceuticals Inc. (Austin, Texas) raised $41 million in a series C round led by Redmile Group. New investors Deerfield and Sabby Capital also participated, as did The McNair Group and other existing investors. Evercore acted as the round's placement agent. ...